Literature DB >> 18392928

Troponin-I elevation in a young man with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

William J Kostis1, Ryan J Tedford, Daniel L Miller, Steven P Schulman, Gordon F Tomaselli.   

Abstract

Ventricular arrhythmias occur frequently in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) as well as those with ischemic heart disease. We present the case of a 29-year-old man with ARVD/C and multiple episodes of symptomatic ventricular tachycardia terminated by implantable cardioverter defibrillator (ICD) discharges. Phasic elevation of troponin-I prompted repeated coronary angiograms, all of which were normal. The patient was successfully treated with radiofrequency ablation. This case illustrates that ARVD/C may result in elevated cardiac enzymes in the absence of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392928     DOI: 10.1007/s10840-008-9250-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  25 in total

1.  Chronic right-sided myocarditis mimicking arrhythmogenic right ventricular dysplasia.

Authors:  P J Michaels; J A Kobashigawa; J S Child; M C Fishbein
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease.

Authors:  Khung Keong Yeo; Luis Cruz; Robert Hong
Journal:  Hawaii Med J       Date:  2006-03

3.  Arrhythmogenic right ventricular dysplasia: a United States experience.

Authors:  Darshan Dalal; Khurram Nasir; Chandra Bomma; Kalpana Prakasa; Harikrishna Tandri; Jonathan Piccini; Ariel Roguin; Crystal Tichnell; Cynthia James; Stuart D Russell; Daniel P Judge; Theodore Abraham; Philip J Spevak; David A Bluemke; Hugh Calkins
Journal:  Circulation       Date:  2005-12-12       Impact factor: 29.690

4.  Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.

Authors:  Srijita Sen-Chowdhry; Petros Syrris; Deirdre Ward; Angeliki Asimaki; Elias Sevdalis; William J McKenna
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

Review 5.  Arrhythmogenic right-ventricular dysplasia/cardiomyopathy.

Authors:  Hugh Calkins
Journal:  Curr Opin Cardiol       Date:  2006-01       Impact factor: 2.161

6.  Evaluation of serum cardiac troponin I concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Ryan D Baumwart; João Orvalho; Kathryn M Meurs
Journal:  Am J Vet Res       Date:  2007-05       Impact factor: 1.156

7.  Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.

Authors:  Koichi Setsuta; Yoshihiko Seino; Takeshi Ogawa; Toshiaki Ohtsuka; Kohji Seimiya; Teruo Takano
Journal:  Circ J       Date:  2004-08       Impact factor: 2.993

8.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

9.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

10.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Darshan Dalal; Rahul Jain; Harikrishna Tandri; Jun Dong; Shaker M Eid; Kalpana Prakasa; Crystal Tichnell; Cynthia James; Theodore Abraham; Stuart D Russell; Sunil Sinha; Daniel P Judge; David A Bluemke; Joseph E Marine; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2007-07-16       Impact factor: 24.094

View more
  4 in total

1.  Angina pectoris with troponin increase in arrhythmogenic right ventricle dysplasia: case article and review of the literature.

Authors:  Jonathan Wagner; Mark H Cohen; Marnie O'Donnell; Linda B Pauliks
Journal:  Pediatr Cardiol       Date:  2012-04       Impact factor: 1.655

2.  Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review.

Authors:  Babken Asatryan; Angeliki Asimaki; Andrew P Landstrom; Mohammed Y Khanji; Katja E Odening; Leslie T Cooper; Francis E Marchlinski; Anna R Gelzer; Christopher Semsarian; Tobias Reichlin; Anjali T Owens; C Anwar A Chahal
Journal:  Circulation       Date:  2021-11-15       Impact factor: 39.918

3.  Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient.

Authors:  Weijia Wang; Cynthia A James; Hugh Calkins
Journal:  Europace       Date:  2019-01-01       Impact factor: 5.214

4.  Can Smartwatch Prevent Sudden Cardiac Deaths? A Case Of Smartwatch Failure in Arrhythmogenic Right Ventricular Dysplasia.

Authors:  Sengottaian Sivakumar; Navdeep Bhatti
Journal:  Cureus       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.